Shares of beaten-down pharmacy stock Walgreens Boots Alliance (NASDAQ: WBA) sank 7.2% today as of 2:47 p.m. ET.
Walgreens had rallied a bit after recent earnings came in better than expected and the company's 2025 outlook came in better than feared. However, fears reemerged on Tuesday, when a big, well-funded rival announced it would begin a same-day prescription delivery service.
Can Walgreens survive in the age of online?
Today, Walmart (NYSE: WMT) announced that it was now open for same-day prescription delivery in six states: Arkansas, Missouri, New York, Nevada, South Carolina, and Wisconsin. The company also noted it would soon roll out same-day prescription delivery to all 49 states by January.
The Walmart announcement is just another in a long line of competitive concerns for Walgreens, which is a legacy brick-and-mortar pharmacy retailer. While Walgreens also has delivery options, large tech-forward retailers like Walmart and Amazon are increasingly targeting the pharmacy space and already have big loyalty programs such as Walmart+ and Amazon Prime. Walmart and Amazon also have the ability to deliver a wide variety of other items along with prescriptions, perhaps giving them an advantage in the online space over legacy pharmacies like Walgreens and CVS.
On its recentearnings call Walgreens investors were encouraged as management unveiled a 1,200-store closure program, which will streamline Walgreens' costly brick-and-mortar footprint and suggested management knows it needs to modernize.
However, even though Walgreens is making progress in its omnichannel efforts and renegotiating drug reimbursement contracts, the online threat isn't going away. Online is also especially damaging to brick-and-mortar pharmacies because if consumers start to get more of their prescriptions online, that could limit foot traffic to Walgreens stores and also affect nondrug sales at its pharmacies.
What to do with Walgreens?
Down 58% on the year and trading at just around 6 times next year's adjusted earnings guidance, Walgreens may seem like a deep value stock. But as today's news shows, the secular headwinds facing the brick-and-mortar pharmacy business aren't going away. Therefore, any turnaround would be difficult and time-consuming, if it happens at all.
Should you invest $1,000 in Walgreens Boots Alliance right now?
Before you buy stock in Walgreens Boots Alliance, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Walgreens Boots Alliance wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $880,670!*
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.
*Stock Advisor returns as of October 21, 2024
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Billy Duberstein and/or his clients has positions in Amazon. The Motley Fool has positions in and recommends Amazon and Walmart. The Motley Fool recommends CVS Health. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
